Genetically Defined Syngeneic Mouse Models of Ovarian Cancer as Tools for the Discovery of Combination ImmunotherapySonia Iyer, Robert A. Weinberg, Sean G. Smith et al.|Cancer Discovery|2020Cited by 138
CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer PrognosisAmanda Sosulski, David Pépin|PLoS ONE|2016Cited by 47